The Pattern

COHR Q2 earnings: book-to-bill >4x, calendar 2026 booked out, 2027 filling fast, visibility "best it's ever been."

Not an isolated signal. Sixth independent confirmation across the optical supply chain:

  • GLW (fiber): Meta $6B deal, optical +35% YoY, hyperscale growth "significantly faster"
  • LITE (transceivers): Undershipping demand 30%, all InP capacity through CY27 committed under LTAs
  • SITM (timing): Book-to-bill >1.5, 7th consecutive quarter >100% YoY, 1.6T oscillator forecast +50%
  • FN (mfg): HPC ramping to $150M/quarter, CPO with 3 customers, Building 10 ahead of schedule
  • VIAV (test): Datacenter now 45% of revenue (single digits 1Y ago), production capacity constraints visible
  • COHR (transceivers/lasers): Book-to-bill >4x, InP shortage expected through 2027+

When six independent companies across fiber, transceivers, precision timing, contract manufacturing, and test equipment all report the same thing—demand exceeding supply, extended visibility, capacity constrained—that's not company-specific execution. That's structural undersupply.

Why COHR's Signal Matters Most

Book-to-bill >4x is extraordinary. Normal is ≈1.0. COHR's customers aren't ordering for next quarter—they're locking in supply through 2027 and receiving 2-3 year forecasts extending into 2028. CEO Anderson: "bookings being booked out through the rest of this calendar year and most of the bookings we're getting now are into calendar '27."

Multiple long-term supply agreements with financial commitments from customers. This isn't speculative demand—it's customers writing checks to guarantee supply.

The 6-inch indium phosphide ramp is ahead of schedule. 80% of year-end capacity target already running, quadrupled wafer starts Q/Q, yields exceeding 3-inch lines. By December, 50% of internal InP capacity will be 6-inch. Cost structure: >4x chips at <50% cost creates structural margin expansion as mix shifts.

The CPO Scale-Up Narrative Is Underpriced

COHR secured a "massive" CPO purchase order from a "market-leading AI datacenter customer." Revenue starts end of CY2026, "more significant contribution" CY2027+.

But Anderson's framing is the sleeper: Scale-up networks (server-to-server within rack) are 100% electrical today. Converting to optical = "all incremental TAM." He said scale-up CPO will "dwarf" scale-out opportunity.

That's not guidance sandbagging. That's a CEO telling you the market doesn't understand the size of what's coming.

Currently, optical interconnects address scale-out (rack-to-rack, datacenter-to-datacenter). Scale-up (within-rack, ultra-short reach) is copper. As AI clusters scale and copper hits physical limits, that entire market converts to optical—and it's larger than the scale-out TAM that's already causing supply shortages.

Supply-Demand Imbalance Persists 2+ Years

Anderson doesn't foresee supply-demand balance "this calendar year" or "next calendar year"—potentially a "very sustained long period of supply-demand imbalance on indium phosphide."

LITE said the same: undershipping demand 30% despite adding 20%+ capacity, all InP through CY27 committed.

VIAV CEO: "if you take all their [hyperscaler] announcements, how much they're gonna spend, how much they're gonna invest, what you have in terms of production capacity you're gonna see significant growth over the next two years."

Three independent CEOs, same message: InP capacity won't catch demand through 2027.

Guidance: FY27 Growth > FY26 Growth

COHR expects FY2027 revenue growth rate to EXCEED FY2026 growth rate. Datacenter to see double-digit sequential growth in both March and June quarters. Both 800G and 1.6T transceivers expected to grow significantly through CY2026.

If you're booking out through 2027, growing double-digit sequential, and telling the street FY27 > FY26, you're not guiding to a peak—you're guiding to a ramp.

What Market Missed

Stock down 3.5% on 2.7x volume day of earnings despite beat and raised guidance. Up 126% over 1Y, so profit-taking makes sense. But:

  • Book-to-bill >4x with 2-3 year customer forecasts = visibility never seen before
  • Scale-up CPO TAM will "dwarf" scale-out = market sizing too conservative
  • FY27 growth > FY26 = acceleration, not deceleration
  • 6-inch InP ahead of schedule = margin expansion trajectory intact
  • Cross-ticker convergence = not COHR-specific, entire optical stack supply-constrained

Street targets $234 mean vs $203 current = 15% to consensus. But if FY27 > FY26 and CPO scale-up is incremental TAM, consensus may be stale.

What Could Go Wrong

Inventory build ($421M in 6mo) could indicate cycle risk, but context supports demand interpretation: book-to-bill >4x, customer LTAs with financial commitments, forward visibility into CY28. Building inventory when you have signed orders extending 2+ years is prudence, not speculation.

Insider selling visible (directors trimming Dec 2025). Stock +126% 1Y, RSI 57 neutral—not a trough entry. Valuation 29x forward P/E is priced for growth.

But the cross-ticker pattern is what matters. When the entire supply chain—fiber, transceivers, timing, test equipment—reports synchronized demand signals with extended visibility through 2027, the question isn't "is COHR cheap" but "is the market pricing the AI optical infrastructure build correctly across all these names?"

Where's the Alpha

Estimate disconnect possible: FY27 > FY26 growth not fully reflected in consensus yet. CPO scale-up TAM expansion (incremental to scale-out) not modeled. 6-inch InP margin trajectory underappreciated.

But real alpha is pattern recognition: Six independent supply chain signals converging = structural shift, not cyclical bounce. Market sees AI capex. May not see optical interconnect capacity constraint lasting 2+ years with pricing power and TAM expansion from scale-up conversion.

The 6-inch InP advantage is structural (>4x chips, <50% cost). COHR ahead of schedule. Competitors can't replicate fast enough to resolve supply-demand imbalance through 2027. That's not a product cycle—that's a capacity advantage in a supply-constrained market with 2-3 year visibility.

What to Do

Not a trough valuation entry (stock -3.5% on beat after +126% run). But if thesis is structural undersupply through 2027 with TAM expansion from CPO scale-up, current multiples may be justified.

Check cross-ticker basket: GLW, LITE, SITM, FN, VIAV all reporting same pattern. Diversify across the stack if concerned about single-name execution risk. Or concentrate on COHR if 6-inch InP advantage + CPO scale-up optionality is the edge.

Gaps to fill:

  • Decompose street estimates: where do analysts have FY27 growth vs COHR guidance?
  • Quantify CPO scale-up TAM: how much scale-up connectivity exists today in electrical form?
  • Compare 6-inch InP roadmaps: is COHR lead time durable or will competitors close gap by 2027?

But don't overthink it. Six companies. Same story. Two-year visibility. Book-to-bill >4x. InP shortage through 2027. That's the signal.